SCHEMBL29339644

SCHEMBL29339644

CC(C)OCC(=O)N1CCC(O)(C(C)F)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
UGT8 Q16880 1/20 0.34
CYP2D6 P10635 8/20 0.34
CYP3A4 P08684 7/20 0.34
USP2 O75604 6/20 0.34
CYP1A2 P05177 3/20 0.33
HIF1A Q16665 1/20 0.33
CYP2C9 P11712 3/20 0.32
TSHR P16473 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
NAMPT P43490 1/20 0.31
MAPK1 P28482 2/20 0.31
CYP2C19 P33261 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26318126 0.79 ALDH1A1 (0.43) ALDH1A1UGT8CYP3A4USP2L3MBTL1
SCHEMBL9911426 0.76 ATM (0.50) ALDH1A1TSHRL3MBTL1KMT2AMEN1
SCHEMBL21999479 0.76 ATM (0.45) ALDH1A1TSHRL3MBTL1KMT2AMEN1
SCHEMBL25481778 0.74 MEN1 (0.49) ALDH1A1L3MBTL1KMT2AMEN1HPGD
SCHEMBL29341868 0.74 ALDH1A1 (0.52) ALDH1A1CYP2D6CYP3A4USP2CYP1A2
SCHEMBL16181037 0.73 ALDH1A1 (0.35) ALDH1A1CYP2D6CYP3A4USP2L3MBTL1
SCHEMBL20061876 0.73 PIK3CD (0.48) ALDH1A1CYP3A4USP2CYP1A2L3MBTL1
SCHEMBL21813931 0.73 MEN1 (0.41) ALDH1A1UGT8CYP3A4USP2L3MBTL1
SCHEMBL7855456 0.73 TDP1 (0.45) ALDH1A1CYP1A2L3MBTL1KMT2AHSD17B10
SCHEMBL20413347 0.71 KDM4E (0.51) ALDH1A1CYP2D6CYP3A4USP2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF UACA, ADCYAP1R1, ADCY1 ALDH1A1 638/4885UGT8 451/4885CYP2D6 1242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.